Histone methyltransferases are a group of enzymes that catalyze the methylation of histone lysine and arginine by adding methyl groups to specific histone arginine or lysine residues. Histone methyltransferaes can be classified into 3 classes, including SET domain lysine methyltransferases, non-SET domain lysine methyltransferases and arginine methyltransferases (PRMTs), all of which use S-adenosylmethionine as a cosubstrate for the transfer of the methyl group. Aberrant histone methylation has been associated with a wide range of human cancers (such as hematological malignancies), which leads to the development of novel cancer chemotherapies targeting cancer-associated histone methyltransferases (more than 20 lysine methyltransferases and 9 arginine methyltransferases in humans).
- Cat.No. Product Name Information
- B6048 SGC707
- B5913 C7280948
- B4989 EPZ015666
- B4949 WDR5 0103
- B4948 UNC 2400
- B4947 A 366
- B4875 PFI-2 PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase with IC50 value of 2.0 nM [1
- B7757 UNC 0642 New Product
- B7756 C 21 New Product
- B7750 TC-E 5003 TC-E 5003 is a selective inhibitor of PRMT1 with IC50 value of 1.5 μM .